Bio-Path Holdings (BPTH) Misses Q2 EPS by 9c

Bio-Path Holdings (NASDAQ: BPTH) reported Q2 EPS of ($0.53), $0.09 worse than the analyst estimate of ($0.44).

For earnings history and earnings-related data on Bio-Path Holdings (BPTH) click here.

You May Also Be Interested In

• Wolfe Research starts Ferrari at Outperform, sees 'solid upside potential'
• MasTec to acquire The Superior Group for about $1.65 billion
• Penguin Solutions (PENG) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY26 EPS Guidance